SNAI2 and TWIST1 in lymph node progression in early stages of NSCLC patients - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Cancer Medicine Année : 2018

SNAI2 and TWIST1 in lymph node progression in early stages of NSCLC patients

Résumé

Lymph node metastasis is an important prognosis factor in non-small cell lung cancer (NSCLC) patients. The aim of this study was to investigate the role of epithelial to mesenchymal transition (EMT) in lymph node progression in the early stages of NSCLC. We studied a retrospective cohort of 160 consecutive surgically treated NSCLC patients with available frozen tumor samples for expression of EMT markers (CDH1, CTNNB1, CDH2, and VIMENTIN), inducers (TGFB1, c-MET, and CAIX), and transcription factors (EMT-TF: SNAI1, SNAI2, ZEB1, TWIST1, and TWIST2). Partial EMT was more frequent in N1-2 (N+) vs N0 patients (P < .01). TGFB1 (P = .02) as well as SNAI2 (P < .01) and TWIST1 (P = .04) were the most differentially expressed genes in N+ tumors. In this group, ZEB1 was correlated with all EMT inducers and other EMT-TFs were overexpressed depending on the inducers. CAIX was an independent prognostic factor for overall survival (IC 95% HR: 1.10-5.14, P = .03). Partial EMT is involved in lymph node progression of NSCLC patients and depends on the TGFβ pathway. EMT-TFs are differentially expressed depending on EMT inducers. CAIX might be a relevant prognostic marker in early stage NSCLC.

Domaines

Cancer
Fichier principal
Vignette du fichier
islandora_141350.pdf (392.38 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-04558449 , version 1 (24-04-2024)

Identifiants

Citer

Camille Emprou, Pauline Le van Quyen, Jeremie Jegu, Nathalie Prim, Noëlle Weingertner, et al.. SNAI2 and TWIST1 in lymph node progression in early stages of NSCLC patients. Cancer Medicine, 2018, 7 (7), pp.3278-3291. ⟨10.1002/cam4.1545⟩. ⟨hal-04558449⟩
0 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More